Peter J. Blankestijn

Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial

Michel Azizi, Roland E. Schmieder, Felix Mahfoud et al. · The Lancet · 2018 · 689 citations · Full text

Hypertension, Urology, Radiance-htn Solo +9

Effect of Online Hemodiafiltration on All-Cause Mortality and Cardiovascular Outcomes

Muriël P.C. Grooteman, Marinus A. van den Dorpel, Michiel L. Bots et al. · Journal of the American Society of Nephrology · 2012 · 512 citations · Full text

Thrombosis, Hemodialysis, Hypertension +13

Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis

Bakhtawar K. Mahmoodi, Kunihiro Matsushita, Mark Woodward et al. · The Lancet · 2012 · 432 citations · Full text

Hemodialysis, Hypertension, Urology +12

Reduction of Sympathetic Hyperactivity by Enalapril in Patients with Chronic Renal Failure

Gerry Ligtenberg, Peter J. Blankestijn, P. Liam Oey et al. · New England Journal of Medicine · 1999 · 408 citations · Full text

Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Christopher T. Chan, Peter J. Blankestijn, Laura M. Dember et al. · Kidney International · 2019 · 404 citations · Full text

Hemodialysis, Renal Disease, Health Policy +13